K562 Cells
USUSD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Insights on K562 cells
| 說明 | The K562 cell line, originating from the bone marrow of a 53-year-old female with chronic myelogenous leukemia, serves as a cornerstone in various research fields such as immunology, tumor immunology, and immune system disorder research. Human K-562 cells are widely used in studies involving immune system interactions, particularly with effector cells like natural killer cells (NK). This is due to their unique characteristics, such as the expression of specific antigens that can be recognized by NK cells. Exploring the interaction between NK cells and cancerous cell lines like K562 offers insights into immune defense mechanisms. NK cells' ability to recognize and respond to K562 cells varies with the presence of specific markers, which fluctuate throughout the K562 cell cycle. K562 cells are characterized by the presence of the Philadelphia chromosome, which results from a translocation between chromosomes 9 and 22, creating the BCR-ABL fusion gene. This fusion gene is not a normal ABL transcript but a mutated form that is constitutively active and leads to uncontrolled cell proliferation. Analyzing ABL transcripts in K562 cells sheds light on leukemia's molecular dynamics and immune evasion strategies. K562 cells are crucial for understanding the cell cycle, particularly for analyzing cell cycle phases and distributions. This analysis is essential for evaluating the impact of ABL gene expression and the associated decrease in ABL fusion transcripts. Furthermore, K562 cells are valuable in assays assessing the cytotoxic effects of FGFR inhibitors and the activity of epigenetic enzymes, highlighting their significance in elucidating cell signaling pathways and the mechanisms of action of various therapeutic agents. The versatility of K562 cells, ranging from their role in enzyme activity assays to their application in immunological studies with natural killer (NK) cells, emphasizes their widespread utility in the scientific realm. This adaptability highlights their significance in bridging the gap between fundamental research and translational medicine, playing a crucial role in advancing the fight against chronic myelogenous leukemia. |
|---|---|
| 生物體 | Human |
| 組織 | Bone marrow |
| 疾病 | Chronic myeloid leukemia |
| 同義詞 | K562, K.562, K 562, KO, GM05372, GM05372E |
Details
| 年齡 | 53 years |
|---|---|
| 性別 | Female |
| 族裔 | Caucasian |
| 形態學 | Round cells |
| 細胞類型 | Lymphoblast |
| 生長特性 | Suspension |
Documentation
| 引用 | K562 (Cytion catalog number 300224) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_0004 |
Genotype of the human K562 cell line
| 抗原表達 | CD7 (25%) |
|---|---|
| 同工酶 | G6PD, B, AK-1, 1, ES-D, 1, GLO-1, 2, PGM1, 0, PGM3, 1, Me-2, 0 |
| 致癌基因 | BCR-ABL1 |
| 致瘤性 | Yes, in nude mice. |
| 逆轉錄酶 | Negative |
Handling
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 傳代培養 | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| 播種密度 | 3 x 105 cells/ml |
| 流體更新 | Every 2 days |
| 解凍後的恢復 | Please allow cells to recover for roughly 24 to 48 hours after thawing. |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality assurance
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 300224-060923 | 分析證明書 | 23. May. 2025 | 300224 |
| 300224-290925 | 分析證明書 | 05. Dec. 2025 | 300224 |
| 300224-270524 | 分析證明書 | 30. Mar. 2026 | 300224 |